Microsoft PowerPoint - Physics Bucharest

543 / 1542

Planning studies:
Improved dose distribution → clinical benefit?
 Organ avoided  less toxicity?
 Better target coverage  better tumor control?
 Lower toxicity  dose-escalation?
 …
23
Clinical use of IMRT: What’s the scientific evidence?
Evidence